Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|November 12, 2025
The evolving landscape of bispecific antibodies in the treatment of lung cancerXuanhong Jin, Chang Chang, Fei Zhou
International Immunopharmacology|October 20, 2024
Exploration of efficacy of the first-line treatment for advanced non-small cell lung cancer with primary MET-amplification: Retrospective evaluation of 36 casesKaibo Ding, Dujiang Liu, Xuanhong Jin, et al.
Autophagy|September 19, 2023
Autophagy in colitis-associated colon cancer: exploring its potential role in reducing initiation and preventing IBD-Related CAC developmentXuanhong Jin, Liangkun You, Jincheng Qiao, et al.
Journal of Imaging Informatics in Medicine|March 4, 2026
MMSeg: Multi-scale Vision Mamba for Lightweight Generalizable Medical Image SegmentationYayuan Mo, Yunhao Chen, Kaiwen Zhu, et al.
Scientific Reports|February 27, 2024
Exploration and machine learning model development for T2 NSCLC with bronchus infiltration and obstructive pneumonia/atelectasisXuanhong Jin, Yang Pan, Chongya Zhai, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 4, 2024
Exploring the Role of Preoperative Systemic Therapy and Primary Resection in NSCLC With Extrathoracic Metastases: Identifying the Optimal CandidatesXuanhong Jin, Xinyu Zhu, Hangchen Shen, et al.
Scientific Reports|June 7, 2024
Developing a prognostic model using machine learning for disulfidptosis related lncRNA in lung adenocarcinomaYang Pan, Xuanhong Jin, Haoting Xu, et al.
Scientific Reports|September 1, 2024
A real world analysis of secondary BRAF variations after targeted therapy resistance in driver gene positive NSCLCDuJiang Liu, KaiBo Ding, KaiLai Yin, et al.
BMC Geriatrics|January 8, 2024
Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic reviewChongya Zhai, Xuanhong Jin, Liangkun You, et al.
Frontiers in Pharmacology|August 20, 2024
Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agentsXuanhong Jin, Yang Pan, Cheng Cheng, et al.
Pageof 2